Table 1.

Summary of outcomes of rifabutin based triple therapy in H. pylori infection

Author(s) and year	Country	Drugs and doses	Duration of treatment (days)	No. of patients	No. of previously failed treatment	Eradication rate (%)
Fiorini G 2018 [18]	Italy.	esomeprazole 40 mg bid, amoxicillin 1 g bid, and rifabutin 150 mg od	12	254	2	82.9% intention-to-treat
Ribaldone DG 2019 [19]	Italy.	Rifabutin 150 mg bid Amoxicillin 1 g bid PPI bid	14	302	2	71.5% intention-to-treat
Van Zanten et al. 2010 [16]	Canada	Rifabutin 300 mg od Amoxicillin 1 g bid PPI bid	7	16	3	63%
Lim et al. 2014 [17]	Korea	Rifabutin 150 mg bid Amoxicillin 1 g tid Lansoprazole 60 mg bid	7	27	2	96.3 intention-to-treat
Lim et al. 2014 [17]	Korea	Rifabutin 150 mg bid Amoxicillin 1 g tid Lansoprazole 30 mg bid	7	32	2	78.1 intention-to-treat
Ierardi et al. 2014 [20]	Italy	Rifabutin 150 mg bid Minocycline 100 mg bid Bismuth 120 mg qid Rabeprazole 20 mg bid	10	21	2	77.7%